RFL MEXC RealStocks
Own real RFL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 16:37:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Rafael Holdings, Inc. (RFL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1.08, with a market capitalization of $55.84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.99 to $3.96. This page covers its latest market performance, valuation, price trends and company information.
$55.84M | |
$1.05 | |
$1.10 | |
$1.05 | |
$1.09 | |
10.64K | |
145.34K | |
-- | |
$3.96 | |
$0.99 | |
-- | |
-- |
Rafael Holdings, Inc. (RFL) is currently trading at $1.08 as of 2026-11-12 16:17:02, down 1.38% ($0.02) from the previous close of $1.09
During today's regular trading session, RFL has traded between $1.05 and $1.10, with a trading volume of 10.64K shares. The current price is near the middle of today's range.
Over the past seven days, Rafael Holdings, Inc. (RFL) moved from $1.08 to $1.08, representing a decline of 0.46% ($0.01).
The stock traded between $0.99 and $1.20 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 75.55 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.9%
RFL is currently trading at $1.08, placing it 2.9% of the way from its 52-week low of $0.99 to its 52-week high of $3.96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 17 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Rafael Holdings, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Rafael Holdings, Inc. (RFL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RFL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between RFL shares and USD.
RFL Shares to USD
1.00 RFL shares = 1.075 USD
Calculations are estimates based on the latest available price and are for reference only.